comparemela.com
Home
Live Updates
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India : comparemela.com
Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin Pioglitazone Fixed-Dose Combination Drug for Type 2 Diabetes in India
Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched a novel fixed-dose combination (FDC) of a widely us
Related Keywords
Mumbai ,
Maharashtra ,
India ,
Teneligliptin Remogliflozin ,
Alok Malik ,
Teneligliptin Pioglitazone ,
Group Vice Presidenthead ,
Biosimilars Companies ,
Glenmark Pharmaceuticals Limited ,
Glenmark Pharmaceuticals ,
International Diabetes Federation ,
Glenmark Pharmaceuticals Ltd ,
Dipeptidyl Peptidase ,
Zita Plus Pio ,
India Formulations ,
Drug Controller General ,
Pharmaceutical Sales ,
Dow Jones Sustainability Index ,
comparemela.com © 2020. All Rights Reserved.